Dasotraline Completed Phase 1 Trials for Pediatric Attention Deficit Hyperactivity Disorder Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02195167Dasotraline SEP360-105 Pediatric PK/PD Study